Viavi signs lease for new global headquarters in Chandler
Viavi Solutions, a tech company that shifted its head office from California to Arizona in 2021, is expanding its footprint in Chandler after realizing it needs more space than it originally anticipated.
Viavi Solutions Inc. (Nasdaq: VIAV) bought a 104,000-square-foot space at the Chandler Airport Commerce Center just south of the airport last year, with the original intent of housing both its global headquarters and manufacturing operations in the facility.
The company has since decided it needed more space, so the HQ staff will now work out of a newly leased 15,000-square-foot office at the Allred Park Place development at 1445 S. Spectrum Blvd in Chandler, just a few miles away from the manufacturing site.
All told, these new operations are expected to support 230 jobs. The company’s career page currently has 12 openings in Chandler.
Viavi makes network testing and optical technologies, with more than 3,600 employees spread over 22 countries. The company’s shares are down about 8.5% year to date. Click here to follow the stock.
“We are excited about this office lease and expect that Viavi will continue to expand within Chandler in the years ahead,” Chandler Mayor Kevin Hartke said in a statement. “Viavi is a world-class advanced manufacturer that is a great fit for Chandler’s highly educated workforce. We appreciate the company’s investment and the high-paying jobs they are bringing to our community.”
Viavi is not the only company growing in Chandler’s Price Corridor. Just last week, General Motors said it planned to hire hundreds at its Arizona IT Innovation Center by the end of the year.
Viavi was based in San Jose, California until last February, when the company announced that it would shift its HQ to the Phoenix metro.
Viavi made several multimillion dollar proposals to acquire Canadian rival EXFO Inc. last summer, all of which were rejected. EXFO’s founder and majority shareholder Germain Lamonde took the company private last year after weeks of squabbling with Viavi.